N-(4-氨基苯基)-2,4-二氯苯甲酰胺 | 293737-94-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: N-(4-氨基苯基)-2,4-二氯苯甲酰胺
• 英文名称: N-(4-aminophenyl)-2,4-dichlorobenzamide
• CAS: 293737-94-7
• 化学式: C₁₃H₁₀Cl₂N₂O
• mdl: MFCD00851342
• 分子量: 281.141
• InChiKey: JFHQBECHISXXKM-UHFFFAOYSA-N

物化性质

• 沸点：
  386.2±42.0 °C(Predicted)
• 密度：
  1.445±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  55.1
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2924299090

反应信息

• 作为产物：
  描述：

  2,4-二氯苯甲酸 、 对苯二胺 在 4-二甲氨基吡啶 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 二氯甲烷 为溶剂， 生成 N-(4-氨基苯基)-2,4-二氯苯甲酰胺
  参考文献：
  名称：

  Small Molecule Modifiers of MicroRNA miR-122 Function for the Treatment of Hepatitis C Virus Infection and Hepatocellular Carcinoma

  摘要：

  MicroRNAs are a recently discovered new class of important endogenous regulators of gene function. Aberrant regulation of microRNAs has been linked to various human diseases, most importantly cancer. Small molecule intervention of microRNA misregulation has the potential to provide new therapeutic approaches to such diseases. Here, we report the first small molecule inhibitors and activators of the liver-specific microRNA miR-122. This microRNA is the most abundant microRNA in the liver and is involved in hepatocellular carcinoma development and hepatitis C virus (HCV) infection. Our small molecule inhibitors reduce viral replication in liver cells and represent a new approach to the treatment of HCV infections. Moreover, small molecule activation of miR-122 in liver cancer cells selectively induced apoptosis through caspase activation, thus having implications in cancer chemotherapy. In addition to providing a new approach for the development of therapeutics, small molecule modifiers of miR-122 function are unique tools for exploring miR-122 biogenesis.

  DOI：

  10.1021/ja910275u

文献信息

• [EN] PROTEIN KINASE INHIBITORS AND USE THEREOF<br/>[FR] INHIBITEURS DE PROTÉINE KINASE ET LEUR UTILISATION
  申请人：MERCK SERONO SA

  公开号：WO2009108670A1

  公开（公告）日：2009-09-03

  Disclosed are benzonaphthyridinyl derivative compounds and analogs thereof, pharmaceutical compositions comprising such compounds and processes for preparing the same. The compounds are useful in the treatment of diseases amenable to kinase signal transduction inhibition, regulation or modulation.

  揭示了苯并萘啶衍生物化合物及其类似物，包括含有这些化合物的药物组合物以及制备这些化合物的方法。这些化合物在治疗对激酶信号传导抑制、调节或调控敏感的疾病中很有用。
• [EN] SMALL MOLECULE MODIFIERS OF MICRORNA MIR-122<br/>[FR] MODIFICATEURS À PETITE MOLÉCULE DE MICROARN MIR-122
  申请人：UNIV NORTH CAROLINA STATE

  公开号：WO2011091209A1

  公开（公告）日：2011-07-28

  MicroRNAs are a class of endogenous regulators of gene function. Aberrant regulation of microRNAs has been linked to various human diseases, most importantly cancer. Small molecule intervention of microRNA misregulation has the potential to provide new therapeutic approaches to such diseases. microRNA miR-122 is the most abundant microRNA in the liver and is involved in hepatocellular carcinoma development and hepatitis C virus (HCV) infection. Small molecule inhibitors and activators of the microRNA miR-122 are described, and methods for their identification are reported. These small molecule inhibitors reduce viral replication in liver cells and thus represent a new approach to the treatment of HCV infections. Moreover, small molecule activation of miR-122 in liver cancer cells selectively induced apoptosis through caspase activation, and thus has implications in cancer chemotherapy.

  微小RNA是一类内源性基因功能调节因子。微小RNA的异常调节与各种人类疾病有关，尤其是癌症。对微小RNA的小分子干预可能为这些疾病提供新的治疗途径。微小RNA miR-122是肝脏中最丰富的微小RNA，参与了肝细胞癌和丙型肝炎病毒（HCV）感染的发展。描述了微小RNA miR-122的小分子抑制剂和激活剂，并报告了其鉴定方法。这些小分子抑制剂可以减少肝细胞中的病毒复制，因此代表了治疗HCV感染的新方法。此外，在肝癌细胞中通过小分子激活miR-122可选择性诱导凋亡，通过激活半胱氨酸蛋白酶而在癌症化疗中具有重要意义。
• PROTEIN KINASE INHIBITORS AND USE THEREOF
  申请人：Huck Bayard R.

  公开号：US20110053906A1

  公开（公告）日：2011-03-03

  Disclosed are benzonaphthyridinyl derivative compounds and analogs thereof, pharmaceutical compositions comprising such compounds and processes for preparing the same. The compounds are useful in the treatment of diseases amenable to kinase signal transduction inhibition, regulation or modulation.

  本发明揭示了苯并萘啉衍生物化合物及其类似物，包括含有这些化合物的制药组合物和制备这些化合物的过程。这些化合物可用于治疗易于激酶信号传导抑制、调节或调控的疾病。
• NAPHTHYRIDINONES AS PROTEIN KINASE INHIBITORS
  申请人：Xiao Yufang

  公开号：US20110269758A1

  公开（公告）日：2011-11-03

  Naphthyridinone derivative compounds that inhibit Aurora kinase enzymes are disclosed along with pharmaceutical compositions comprising these compounds and methods for synthesizing the same. Such compounds have utility in the treatment of proliferative diseases resulting from unregulated and/or disturbed Aurora kinases such as cancers, psoriasis, viral and bacterial infections, inflammatory and autoimmune diseases.

  本发明揭示了抑制Aurora激酶酶的萘啶酮衍生物化合物，以及包含这些化合物的制药组合物和合成这些化合物的方法。这些化合物在治疗由未调节和/或扰动的Aurora激酶引起的增殖性疾病中具有实用性，如癌症、银屑病、病毒和细菌感染、炎症性和自身免疫性疾病。
• SMALL MOLECULE MODIFIERS OF MICRORNA MIR-122
  申请人：Deiters Alexander

  公开号：US20130005759A1

  公开（公告）日：2013-01-03

  MicroRNAs are a class of endogenous regulators of gene function. Aberrant regulation of microRNAs has been linked to various human diseases, most importantly cancer. Small molecule intervention of microRNA misregulation has the potential to provide new therapeutic approaches to such diseases. microRNA miR-122 is the most abundant microRNA in the liver and is involved in hepatocellular carcinoma development and hepatitis C virus (HCV) infection. Small molecule inhibitors and activators of the microRNA miR-122 are described, and methods for their identification are reported. These small molecule inhibitors reduce viral replication in liver cells and thus represent a new approach to the treatment of HCV infections. Moreover, small molecule activation of miR-122 in liver cancer cells selectively induced apoptosis through caspase activation, and thus has implications in cancer chemotherapy.

  MicroRNAs是一类内源性基因调控因子。微小RNA的异常调控已与各种人类疾病，尤其是癌症相关联。小分子干预微小RNA的错调可能为这些疾病提供新的治疗方法。微小RNA miR-122是肝脏中最丰富的微小RNA，参与肝细胞癌的发展和丙型肝炎病毒（HCV）感染。描述了微小RNA miR-122的小分子抑制剂和激活剂，并报道了其鉴定方法。这些小分子抑制剂能够减少肝细胞中的病毒复制，因此代表了治疗HCV感染的新方法。此外，小分子激活miR-122在肝癌细胞中选择性地通过caspase激活诱导凋亡，因此在癌症化疗中具有重要意义。